Skip to Content

Opening BellUS Market Tracker

Markets Companies Macro Earnings Calendar Close-Up Guide Watchlist

News

Market and company headlines

ARTVAll

A personal project for following the US markets. Free, ad-free and open source.

Market

Markets
Companies
Macro
Earnings
Calendar
Compare

Reading

Guide
Close-Up
News
Brief Archive
RSS

Account

Watchlist
Settings
Privacy

© 2026 Opening BellPrivacyNot Investment AdviceAhmet Akyapı

Markets Earnings Close-Up Menu

Nasdaq 100 · QQQ716.90− 0.11%S&P 500 · SPY769.40− 0.49%Dow Jones · DIA533.79− 0.58%Russell 2000 · IWM295.25+ 0.02%

Artiva Biotherapeutics: Targeting A Potentially Lucrative Niche
Artiva Biotherapeutics advances AlloNK NK cell therapy for refractory rheumatoid arthritis; early data shows 71% ACR50 and safety. Click for more on ARTV stock.
SeekingAlpha17 days agoARTV